Most explicit evidence grading
37/50
3rd of 5
| Corpus & currency | Citation fidelity | Retrieval precision | Point-of-care fit | Access & eligibility |
|---|---|---|---|---|
| 9/10 | 10/10 | 7/10 | 6/10 | 5/10 |
- Best for
- Clinicians who need to know how strong the underlying evidence is before acting on it. DynaMed labels conclusions with explicit levels of evidence and GRADE-based grades from systematic surveillance of more than 3,300 journals and over 250 guideline organisations.
- Limitation
- Its generative layer, Dyna AI, is a paid add-on rather than the core product. Retrieval reaches the chart through HL7 Infobutton and toolbar links rather than a SMART on FHIR embed, and there is no free tier for individual clinicians.
- Price
- $399/year individual; $475/year with Dyna AI; $149/year student
Dimension-by-dimension rubric criteria for clinical evidence retrieval tools
- Corpus & currency9/10
Category high: 10/10
Size and breadth of the indexed literature, coverage of guidelines alongside primary papers, refresh cadence, and whether rarer clinical questions are represented rather than only common presentations.
- Citation fidelity10/10
Category high: 10/10
Whether every citation resolves to a real, retrievable source; whether the cited source actually supports the sentence it is attached to; and whether the strength of that evidence is graded rather than asserted.
- Retrieval precision7/10
Category high: 10/10
Whether the tool returns the evidence that answers the question asked, including negative and equivocal findings, and whether you can audit why a given source was selected over the alternatives.
- Point-of-care fit6/10
Category high: 8/10
Whether retrieval fits the ninety seconds actually available during an encounter: latency, mobile access, in-chart reach through SMART on FHIR or Infobutton, and offline availability.
- Access & eligibility5/10
Category high: 10/10
Published pricing, free tier, credential gating such as a US NPI requirement, regional availability, and language coverage.


